(GEN) Gen Digital - Ratings and Ratios
Antivirus, Vpn, Identity, Cleanup, Optimization
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.90% |
| Yield on Cost 5y | 3.04% |
| Yield CAGR 5y | -55.28% |
| Payout Consistency | 86.5% |
| Payout Ratio | 20.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.7% |
| Value at Risk 5%th | 39.9% |
| Relative Tail Risk | -9.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.53 |
| Alpha | -27.11 |
| CAGR/Max DD | 0.17 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.453 |
| Beta | 0.912 |
| Beta Downside | 1.029 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.66% |
| Mean DD | 11.51% |
| Median DD | 10.61% |
Description: GEN Gen Digital October 16, 2025
Gen Digital Inc. (NASDAQ: GEN) provides cyber-safety solutions to consumers, families and small businesses through a portfolio that includes Norton, Avast, LifeLock, MoneyLion, Avira, AVG and CCleaner. The firm’s offerings span security and performance management, identity protection, online privacy and a technology platform. Formerly NortonLifeLock, the company rebranded to Gen Digital in November 2022 and is headquartered in Tempe, Arizona.
Key metrics from the most recent fiscal year show revenue of roughly $2.2 billion, with an adjusted EBITDA margin near 15 % and a subscriber base exceeding 50 million paid users. Growth is being driven by rising consumer demand for privacy tools and the broader macro trend of increasing corporate cybersecurity spend, which the IDC forecasts to grow at a CAGR of ~12 % through 2027. A notable sector pressure is the tightening of data-protection regulations (e.g., GDPR, CCPA), which tends to boost demand for identity-theft protection services.
If you want to dig deeper into GEN’s valuation assumptions and scenario analysis, ValueRay’s analytics platform can help you model the impact of different growth and margin trajectories.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (570.0m TTM) > 0 and > 6% of Revenue (6% = 268.4m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -5.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -28.24% (prev -67.46%; Δ 39.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.32b > Net Income 570.0m (YES >=105%, WARN >=100%) |
| Net Debt (8.08b) to EBITDA (2.06b) ratio: 3.92 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (624.0m) change vs 12m ago 0.32% (target <= -2.0% for YES) |
| Gross Margin 79.32% (prev 80.38%; Δ -1.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 28.38% (prev 24.91%; Δ 3.47pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.78 (EBITDA TTM 2.06b / Interest Expense TTM 578.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.40
| (A) -0.08 = (Total Current Assets 1.29b - Total Current Liabilities 2.55b) / Total Assets 16.05b |
| (B) 0.01 = Retained Earnings (Balance) 217.0m / Total Assets 16.05b |
| (C) 0.10 = EBIT TTM 1.61b / Avg Total Assets 15.76b |
| (D) 0.18 = Book Value of Equity 2.46b / Total Liabilities 13.59b |
| Total Rating: 0.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.04
| 1. Piotroski 2.0pt |
| 2. FCF Yield 5.32% |
| 3. FCF Margin 29.06% |
| 4. Debt/Equity 3.57 |
| 5. Debt/Ebitda 3.92 |
| 6. ROIC - WACC (= 2.04)% |
| 7. RoE 24.67% |
| 8. Rev. Trend 90.82% |
| 9. EPS Trend 94.88% |
What is the price of GEN shares?
Over the past week, the price has changed by -0.64%, over one month by -0.81%, over three months by -12.30% and over the past year by -13.01%.
Is GEN a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the GEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.3 | 26.4% |
| Analysts Target Price | 33.3 | 26.4% |
| ValueRay Target Price | 25.3 | -4.2% |
GEN Fundamental Data Overview November 25, 2025
P/E Trailing = 29.1648
P/E Forward = 10.4493
P/S = 3.6592
P/B = 6.6629
P/EG = 0.6855
Beta = 1.111
Revenue TTM = 4.47b USD
EBIT TTM = 1.61b USD
EBITDA TTM = 2.06b USD
Long Term Debt = 8.42b USD (from longTermDebt, last quarter)
Short Term Debt = 289.0m USD (from shortTermDebt, last quarter)
Debt = 8.77b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.08b USD (from netDebt column, last quarter)
Enterprise Value = 24.45b USD (16.37b + Debt 8.77b - CCE 691.0m)
Interest Coverage Ratio = 2.78 (Ebit TTM 1.61b / Interest Expense TTM 578.0m)
FCF Yield = 5.32% (FCF TTM 1.30b / Enterprise Value 24.45b)
FCF Margin = 29.06% (FCF TTM 1.30b / Revenue TTM 4.47b)
Net Margin = 12.74% (Net Income TTM 570.0m / Revenue TTM 4.47b)
Gross Margin = 79.32% ((Revenue TTM 4.47b - Cost of Revenue TTM 925.0m) / Revenue TTM)
Gross Margin QoQ = 78.20% (prev 78.76%)
Tobins Q-Ratio = 1.52 (Enterprise Value 24.45b / Total Assets 16.05b)
Interest Expense / Debt = 1.66% (Interest Expense 146.0m / Debt 8.77b)
Taxrate = 42.49% (99.0m / 233.0m)
NOPAT = 923.6m (EBIT 1.61b * (1 - 42.49%))
Current Ratio = 0.51 (Total Current Assets 1.29b / Total Current Liabilities 2.55b)
Debt / Equity = 3.57 (Debt 8.77b / totalStockholderEquity, last quarter 2.46b)
Debt / EBITDA = 3.92 (Net Debt 8.08b / EBITDA 2.06b)
Debt / FCF = 6.22 (Net Debt 8.08b / FCF TTM 1.30b)
Total Stockholder Equity = 2.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.55% (Net Income 570.0m / Total Assets 16.05b)
RoE = 24.67% (Net Income TTM 570.0m / Total Stockholder Equity 2.31b)
RoCE = 14.97% (EBIT 1.61b / Capital Employed (Equity 2.31b + L.T.Debt 8.42b))
RoIC = 8.49% (NOPAT 923.6m / Invested Capital 10.89b)
WACC = 6.44% (E(16.37b)/V(25.14b) * Re(9.38%) + D(8.77b)/V(25.14b) * Rd(1.66%) * (1-Tc(0.42)))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.64%
[DCF Debug] Terminal Value 74.14% ; FCFE base≈1.63b ; Y1≈1.69b ; Y5≈1.92b
Fair Price DCF = 43.30 (DCF Value 26.70b / Shares Outstanding 616.7m; 5y FCF grow 3.71% → 3.0% )
EPS Correlation: 94.88 | EPS CAGR: 9.58% | SUE: 0.67 | # QB: 0
Revenue Correlation: 90.82 | Revenue CAGR: 15.88% | SUE: 0.96 | # QB: 3
Additional Sources for GEN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle